NFL Biosciences Statistics

Total Valuation

NFL Biosciences has a market cap or net worth of EUR 18.38 million.

Market Cap	18.38M
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

NFL Biosciences has 9.71 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	9.71M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	22.97%
Owned by Institutions (%)	0.26%
Float	7.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	3.02
P/TBV Ratio	5.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.16, with a Debt / Equity ratio of 0.03.

Current Ratio	19.16
Quick Ratio	18.44
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,676.33

Financial Efficiency

Return on equity (ROE) is -56.92% and return on invested capital (ROIC) is -31.25%.

Return on Equity (ROE)	-56.92%
Return on Assets (ROA)	-26.45%
Return on Capital (ROIC)	-31.25%
Revenue Per Employee	20
Profits Per Employee	-489,122
Employee Count	2
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +32.36% in the last 52 weeks. The beta is 1.54, so NFL Biosciences's price volatility has been higher than the market average.

Beta (5Y)	1.54
52-Week Price Change	+32.36%
50-Day Moving Average	1.90
200-Day Moving Average	2.13
Relative Strength Index (RSI)	50.30
Average Volume (20 Days)	15,989

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NFL Biosciences had revenue of EUR 39 and -978,243 in losses. Loss per share was -0.19.

Revenue	39
Gross Profit	-530,694
Operating Income	-901,867
Pretax Income	-1.12M
Net Income	-978,243
EBITDA	-858,366
EBIT	-901,867
Loss Per Share	-0.19

Full Income Statement

Balance Sheet

The company has 3.20 million in cash and 85,007 in debt, giving a net cash position of 3.12 million or 0.32 per share.

Cash & Cash Equivalents	3.20M
Total Debt	85,007
Net Cash	3.12M
Net Cash Per Share	0.32
Equity (Book Value)	3.29M
Book Value Per Share	0.63
Working Capital	3.37M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,312,479.49%
Pretax Margin	-2,870,535.90%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NFL Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-9.87%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NFL Biosciences has an Altman Z-Score of 27.22.

Altman Z-Score	27.22
Piotroski F-Score	n/a